South Korea · Delayed Price · Currency is KRW Kyongbo Pharmaceutical Statistics
Total Valuation
KRX:214390 has a market cap or net worth of KRW 121.21 billion. The enterprise value is 265.38 billion.
| Market Cap | 121.21B |
| Enterprise Value | 265.38B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:214390 has 23.91 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 23.91M |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 17.15% |
| Owned by Institutions (%) | 0.08% |
| Float | 9.15M |
Valuation Ratios
The trailing PE ratio is 24.03.
| PE Ratio | 24.03 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.14 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 52.60 |
| EV / Sales | 0.95 |
| EV / EBITDA | 12.69 |
| EV / EBIT | 39.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 1.07.
| Current Ratio | 0.88 |
| Quick Ratio | 0.44 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 9.44 |
| Debt / FCF | -3.59 |
| Interest Coverage | 0.61 |
Financial Efficiency
Return on equity (ROE) is 3.49% and return on invested capital (ROIC) is 0.78%.
| Return on Equity (ROE) | 3.49% |
| Return on Assets (ROA) | 0.48% |
| Return on Invested Capital (ROIC) | 0.78% |
| Return on Capital Employed (ROCE) | 1.51% |
| Weighted Average Cost of Capital (WACC) | 3.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.82 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, KRX:214390 has paid 931.95 million in taxes.
| Income Tax | 931.95M |
| Effective Tax Rate | 15.59% |
Stock Price Statistics
The stock price has increased by +2.22% in the last 52 weeks. The beta is 0.33, so KRX:214390's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +2.22% |
| 50-Day Moving Average | 5,188.40 |
| 200-Day Moving Average | 5,944.00 |
| Relative Strength Index (RSI) | 44.01 |
| Average Volume (20 Days) | 26,283 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:214390 had revenue of KRW 279.55 billion and earned 5.05 billion in profits. Earnings per share was 210.97.
| Revenue | 279.55B |
| Gross Profit | 107.47B |
| Operating Income | 2.63B |
| Pretax Income | 5.98B |
| Net Income | 5.05B |
| EBITDA | 16.74B |
| EBIT | 2.63B |
| Earnings Per Share (EPS) | 210.97 |
Balance Sheet
The company has 13.83 billion in cash and 158.00 billion in debt, with a net cash position of -144.17 billion or -6,030.60 per share.
| Cash & Cash Equivalents | 13.83B |
| Total Debt | 158.00B |
| Net Cash | -144.17B |
| Net Cash Per Share | -6,030.60 |
| Equity (Book Value) | 146.99B |
| Book Value Per Share | 6,129.28 |
| Working Capital | -23.65B |
Cash Flow
In the last 12 months, operating cash flow was 11.95 billion and capital expenditures -55.93 billion, giving a free cash flow of -43.98 billion.
| Operating Cash Flow | 11.95B |
| Capital Expenditures | -55.93B |
| Depreciation & Amortization | 14.11B |
| Net Borrowing | 44.27B |
| Free Cash Flow | -43.98B |
| FCF Per Share | -1,839.63 |
Margins
Gross margin is 38.44%, with operating and profit margins of 0.94% and 1.80%.
| Gross Margin | 38.44% |
| Operating Margin | 0.94% |
| Pretax Margin | 2.14% |
| Profit Margin | 1.80% |
| EBITDA Margin | 5.99% |
| EBIT Margin | 0.94% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.69% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 1.07% |
| Earnings Yield | 4.16% |
| FCF Yield | -36.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:214390 has an Altman Z-Score of 1.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.47 |
| Piotroski F-Score | 4 |